As clinical studies have indicated constitutive activation of Ras/ERK and Jak/STAT signaling in all cases of the clinical HCC samples analyzed (n > 80),89 the inhibitors tested in the Xmrk transgenic zebrafish may also be capable of regressing human HCC. Here, SOAT1 is linked to hepatocellular carcinoma.